Janus Henderson Group Portfolio holdings
Janus Henderson Group, formed in 2017 through the merger of Janus Capital Group (founded 1969) and Henderson Group (founded 1934), is a global asset management firm headquartered in London, managing over $350 billion in assets as of late 2024 for institutional, retail, and high-net-worth clients. With a strong presence in the U.S., Europe, and Asia-Pacific, the firm offers a wide range of investment products, including equities, fixed income, multi-asset, and alternative strategies, often blending active management with research-driven insights. Known for its equity expertise from Janus’s growth-focused heritage and Henderson’s European fixed-income strengths, Janus Henderson serves clients through mutual funds, ETFs, and bespoke portfolios, emphasizing risk-adjusted returns and ESG integration. Led by CEO Ali Dibadj since 2022, the publicly traded firm (NYSE: JHG) continues to refine its strategy amid competitive pressures, maintaining a foothold in key markets worldwide.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
United Parcel Service
UPS
|
+$428M |
| 2 |
DexCom
DXCM
|
+$384M |
| 3 |
WIX.com
WIX
|
+$359M |
| 4 |
FTCH
Farfetch Limited Class A Ordinary Shares
FTCH
|
+$254M |
| 5 |
Caesars Entertainment
CZR
|
+$246M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Apple
AAPL
|
+$1.14B |
| 2 |
Microchip Technology
MCHP
|
+$535M |
| 3 |
Merck
MRK
|
+$512M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$444M |
| 5 |
Illumina
ILMN
|
+$413M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 30.59% |
| 2 | Healthcare | 18.35% |
| 3 | Consumer Discretionary | 11.3% |
| 4 | Financials | 10.45% |
| 5 | Communication Services | 9.62% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
1226
American Financial Group
AFG
$12B
| $2.12M | ﹤0.01% |
16,980
-2,887
| -15% | -$361K |
|
1227
Genpact
G
$6.14B
| $2.12M | ﹤0.01% |
46,554
-143,277
| -75% | -$6.49M |
|
1228
Erie Indemnity
ERIE
$12.8B
| $2.1M | ﹤0.01% |
10,840
-61,531
| -85% | -$12.7M |
|
|
HBI
1229
DELISTED
Hanesbrands
HBI
| $2.09M | ﹤0.01% |
+111,902
| New | +$2.22M |
|
1230
LeMaitre Vascular
LMAT
$2.35B
| $2.07M | ﹤0.01% |
33,854
-4,356
| -11% | -$231K |
|
1231
ACM Research
ACMR
$4.62B
| $2.06M | ﹤0.01% |
60,615
-2,946
| -5% | -$80.9K |
|
1232
Five Below
FIVE
$11.6B
| $2.06M | ﹤0.01% |
10,664
-9,555
| -47% | -$1.82M |
|
1233
Molson Coors Class B
TAP
$8.13B
| $2.05M | ﹤0.01% |
38,152
-31,766
| -45% | -$1.77M |
|
|
AEPPZ
1234
DELISTED
American Electric Power Company, Inc. Corporate Units
AEPPZ
| $2.05M | ﹤0.01% |
40,000
| – | – |
|
1235
Autoliv
ALV
$9.17B
| $2.04M | ﹤0.01% |
20,814
+2,077
| +11% | +$209K |
|
1236
US Foods
USFD
$22.7B
| $2.02M | ﹤0.01% |
+52,674
| New | +$2.04M |
|
1237
908 Devices
MASS
$316M
| $2M | ﹤0.01% |
51,682
-29,116
| -36% | -$1.32M |
|
1238
Alnylam Pharmaceuticals
ALNY
$38.5B
| $1.99M | ﹤0.01% |
11,725
-6,458
| -36% | -$946K |
|
1239
The Joint Corp
JYNT
$121M
| $1.96M | ﹤0.01% |
23,406
-2,967
| -11% | -$184K |
|
|
WKME
1240
DELISTED
WalkMe Ltd. Ordinary Shares
WKME
| $1.95M | ﹤0.01% |
+66,668
| New | +$1.98M |
|
1241
SiriusXM
SIRI
$10.7B
| $1.93M | ﹤0.01% |
29,496
+82
| +0.3% | +$5.14K |
|
1242
Eledon Pharmaceuticals
ELDN
$261M
| $1.93M | ﹤0.01% |
245,095
+31,196
| +15% | +$294K |
|
|
ONTF
1243
DELISTED
ON24
ONTF
| $1.92M | ﹤0.01% |
+54,231
| New | +$2.12M |
|
1244
NRC Health Common Stock
NRC
$473M
| $1.92M | ﹤0.01% |
41,789
-5,904
| -12% | -$281K |
|
1245
Pinnacle Financial Partners Inc
PNFP
$15.8B
| $1.92M | ﹤0.01% |
21,702
-2,249
| -9% | -$201K |
|
1246
Janus Henderson AAA CLO ETF
JAAA
$29.1B
| $1.87M | ﹤0.01% |
37,100
-378,335
| -91% | -$19.1M |
|
1247
Camden Property Trust
CPT
$11.5B
| $1.87M | ﹤0.01% |
14,079
-36,622
| -72% | -$4.54M |
|
1248
Owens Corning
OC
$11B
| $1.83M | ﹤0.01% |
18,657
+1,306
| +8% | +$130K |
|
1249
SentinelOne
S
$6.26B
| $1.83M | ﹤0.01% |
+42,713
| New | +$1.82M |
|
1250
Incyte
INCY
$25.5B
| $1.82M | ﹤0.01% |
21,641
-22,746
| -51% | -$1.9M |
|
Similar funds
Janus Henderson Group's Q2 2021 Portfolio in Review
As of Q2 2021, Janus Henderson Group held 1,725 positions worth $234B, up 6.7% from $219B the previous quarter. Its ten largest holdings account for 23% of the portfolio.
Janus Henderson Group's Q2 2021 filing shows 172 new, 741 increased, 667 reduced and 123 closed positions. Its largest new stake was Centessa Pharmaceuticals: 5,680,933 shares worth $120M. The largest sale was Apple, an estimated $1.14B.
By sector, the portfolio is most concentrated in Technology at 31% of assets, up from 31% a quarter earlier, followed by Healthcare and Consumer Discretionary.
- Janus Henderson Group's largest Q2 2021 buy was Centessa Pharmaceuticals: 5,680,933 shares worth $120M.
- Janus Henderson Group added most to United Parcel Service in Q2 2021, an estimated $428M increase.
- Janus Henderson Group's biggest Q2 2021 reduction was Apple, cutting an estimated $1.14B.
- Janus Henderson Group fully exited PRA Health Sciences, Inc. in Q2 2021, selling an estimated $368M.
- Janus Henderson Group's ten largest holdings make up 23% of its $234B portfolio in Q2 2021.
- Janus Henderson Group opened 172 new positions and closed 123 in Q2 2021.
- Janus Henderson Group's portfolio value rose 6.7% quarter-over-quarter to $234B.
Based on Janus Henderson Group's 13F filing for Q2 2021, filed 16 Aug 2021.